REPORT ID 13327

United States Drug Coated Endotracheal Tube Market Report 2017

Publish Date
21-Nov-17
Pages
103
Format
Electronic (PDF)

In this report, the United States Drug Coated Endotracheal Tube market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
    The West
    Southwest
    The Middle Atlantic
    New England
    The South
    The Midwest
with sales (volume), revenue (value), market share and growth rate of Drug Coated Endotracheal Tube in these regions, from 2012 to 2022 (forecast).

United States Drug Coated Endotracheal Tube market competition by top manufacturers/players, with Drug Coated Endotracheal Tube sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    Bard Medical
    Teleflex
    Airway Innovations LLC
    Allvivo Vascular
    Brio Device
    ...

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Antithrombotic Drug Coated
    Antiproliferative Drug Coated
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    BPH
    Ureteral Stenosis
    Prostatic Cancer
    Esophageal Stricture
    Sinus Stenosis
    Biliary Stricture

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

United States Drug Coated Endotracheal Tube Market Report 2017
1 Drug Coated Endotracheal Tube Overview
    1.1 Product Overview and Scope of Drug Coated Endotracheal Tube
    1.2 Classification of Drug Coated Endotracheal Tube by Product Category
        1.2.1 United States Drug Coated Endotracheal Tube Market Size (Sales Volume) Comparison by Type (2012-2022)
        1.2.2 United States Drug Coated Endotracheal Tube Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
        1.2.3 Antithrombotic Drug Coated
        1.2.4 Antiproliferative Drug Coated
    1.3 United States Drug Coated Endotracheal Tube Market by Application/End Users
        1.3.1 United States Drug Coated Endotracheal Tube Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
        1.3.2 BPH
        1.3.3 Ureteral Stenosis
        1.3.4 Prostatic Cancer
        1.3.5 Esophageal Stricture
        1.3.6 Sinus Stenosis
        1.3.7 Biliary Stricture
    1.4 United States Drug Coated Endotracheal Tube Market by Region
        1.4.1 United States Drug Coated Endotracheal Tube Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 The West Drug Coated Endotracheal Tube Status and Prospect (2012-2022)
        1.4.3 Southwest Drug Coated Endotracheal Tube Status and Prospect (2012-2022)
        1.4.4 The Middle Atlantic Drug Coated Endotracheal Tube Status and Prospect (2012-2022)
        1.4.5 New England Drug Coated Endotracheal Tube Status and Prospect (2012-2022)
        1.4.6 The South Drug Coated Endotracheal Tube Status and Prospect (2012-2022)
        1.4.7 The Midwest Drug Coated Endotracheal Tube Status and Prospect (2012-2022)
    1.5 United States Market Size (Value and Volume) of Drug Coated Endotracheal Tube (2012-2022)
        1.5.1 United States Drug Coated Endotracheal Tube Sales and Growth Rate (2012-2022)
        1.5.2 United States Drug Coated Endotracheal Tube Revenue and Growth Rate (2012-2022)

2 United States Drug Coated Endotracheal Tube Market Competition by Players/Suppliers
    2.1 United States Drug Coated Endotracheal Tube Sales and Market Share of Key Players/Suppliers (2012-2017)
    2.2 United States Drug Coated Endotracheal Tube Revenue and Share by Players/Suppliers (2012-2017)
    2.3 United States Drug Coated Endotracheal Tube Average Price by Players/Suppliers (2012-2017)
    2.4 United States Drug Coated Endotracheal Tube Market Competitive Situation and Trends
        2.4.1 United States Drug Coated Endotracheal Tube Market Concentration Rate
        2.4.2 United States Drug Coated Endotracheal Tube Market Share of Top 3 and Top 5 Players/Suppliers
        2.4.3 Mergers & Acquisitions, Expansion in United States Market
    2.5 United States Players/Suppliers Drug Coated Endotracheal Tube Manufacturing Base Distribution, Sales Area, Product Type

3 United States Drug Coated Endotracheal Tube Sales (Volume) and Revenue (Value) by Region (2012-2017)
    3.1 United States Drug Coated Endotracheal Tube Sales and Market Share by Region (2012-2017)
    3.2 United States Drug Coated Endotracheal Tube Revenue and Market Share by Region (2012-2017)
    3.3 United States Drug Coated Endotracheal Tube Price by Region (2012-2017)

4 United States Drug Coated Endotracheal Tube Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
    4.1 United States Drug Coated Endotracheal Tube Sales and Market Share by Type (Product Category) (2012-2017)
    4.2 United States Drug Coated Endotracheal Tube Revenue and Market Share by Type (2012-2017)
    4.3 United States Drug Coated Endotracheal Tube Price by Type (2012-2017)
    4.4 United States Drug Coated Endotracheal Tube Sales Growth Rate by Type (2012-2017)

5 United States Drug Coated Endotracheal Tube Sales (Volume) by Application (2012-2017)
    5.1 United States Drug Coated Endotracheal Tube Sales and Market Share by Application (2012-2017)
    5.2 United States Drug Coated Endotracheal Tube Sales Growth Rate by Application (2012-2017)
    5.3 Market Drivers and Opportunities

6  United States Drug Coated Endotracheal Tube Players/Suppliers Profiles and Sales Data
    6.1 Bard Medical
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Drug Coated Endotracheal Tube Product Category, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Bard Medical Drug Coated Endotracheal Tube Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Teleflex
        6.2.2 Drug Coated Endotracheal Tube Product Category, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Teleflex Drug Coated Endotracheal Tube Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Airway Innovations LLC
        6.3.2 Drug Coated Endotracheal Tube Product Category, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Airway Innovations LLC Drug Coated Endotracheal Tube Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Allvivo Vascular
        6.4.2 Drug Coated Endotracheal Tube Product Category, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Allvivo Vascular Drug Coated Endotracheal Tube Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Brio Device
        6.5.2 Drug Coated Endotracheal Tube Product Category, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Brio Device Drug Coated Endotracheal Tube Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    ...

7 Drug Coated Endotracheal Tube Manufacturing Cost Analysis
    7.1 Drug Coated Endotracheal Tube Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Drug Coated Endotracheal Tube

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Drug Coated Endotracheal Tube Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Drug Coated Endotracheal Tube Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 United States Drug Coated Endotracheal Tube Market Size (Value and Volume) Forecast (2017-2022)
    11.1 United States Drug Coated Endotracheal Tube Sales Volume, Revenue Forecast (2017-2022)
    11.2 United States Drug Coated Endotracheal Tube Sales Volume Forecast by Type (2017-2022)
    11.3 United States Drug Coated Endotracheal Tube Sales Volume Forecast by Application (2017-2022)
    11.4 United States Drug Coated Endotracheal Tube Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer